Fledgling cannabis company has wings clipped by NZX
Medical cannabis company with a chequered past "not suitable" for stock exchange listing.
AdvertisementAdvertise with NZME.
Latest fromMarkets
Travel bubble: Three big business winners - and why Air NZ will still be in the red
Which stocks will be the winners from the transtasman bubble opening?
'We have come out of the year battle-hardened': NZX chairman
James Miller apologises for trading disruption caused by last year's cyber attacks.
NZX website off to a slow start due to technical issue
Delivery of share prices on the NZX's website was delayed by about an hour this morning.
Market Watch: Covid crash one year on - the biggest winners
After a huge initial slump shares have soared through the 12 months of the pandemic.
Will Synlait's 'perfect storm' mean another capital raise?
Synlait is now looking at breakeven this year. Will it need to raise more capital?
Opinion: Cross-border IPO boom is rich in promise — and peril
Financial Times: Some investors may become wealthy while others are left holding the bag.
Accounting for Covid: PwC finds firms taking hit in impairments and inventory buildup
PwC says the impact of Covid-19 on financial reporting has been significant.
S&P 500 returns to a record high after best day in weeks
US stocks burst to the best day in weeks, helping Wall Street return to record heights.
Downtrodden stock pickers see opportunity in rebound
Financial Times: Recovering US economy brings chance to beat passive rivals.
How the NZX's top 50 companies weathered worst of Covid
Companies tapped up the banks and investors for support.
Opinion: Emissions offsets can protect our heritage better than Climate Commission
The Climate Commission threatens a number of sectors.
How the Biden stimulus has poured fuel on a global market shake-up
Financial Times: Stocks left behind at height of pandemic pull ahead as tech falters.
Cathie Wood: A tech investor doing God's work
Financial Times: Wildly successful fund manager rides her go-go investment creed.
How long can NZ dairy prices remain high?
Will today's historically high milk prices prompt overproduction and a price slump?
Jarden Brief: Elon Musk adds US$25 billion to his wealth
Jarden's daily update on the latest market moves and shakes.
Rise of the retail army: The amateur traders transforming markets
Financial Times: Growth of retail trading is forcing mainstream investors to take note.
NZ's Mondiale ponders IPO after Aussie freight merger
NZ's Mondiale is merging with Visa Global Logistics and may launch an IPO.
Market Watch: Why good news is bad news for sharemarkets
Covid recovery lifting bond yields and deflating shares - how should investors respond?
Rio Tinto chair quits over destruction of ancient Indigenous caves
The mining giant blasted the 46,000-year-old heritage site in May last year.
Market close: NZ sharemarket shrugs off lockdown, focuses on Aussie QE
More bond buying in Australia leads Kiwi shares higher.
Rocket Lab tipped for $6b moonshot on to Nasdaq
Deal would see US-NZ startup and Mahia spaceport operator soar in value.
Business Hub: Oliver Mander on why retail investors are on the rise
Why retail investors are on the rise.
Australia sovereign wealth fund chief warns of stock market 'clean-out'
Financial Times: Some asset prices are 'unsustainable'.
Kiwi businesses are enjoying a good results season - so what's eating the NZX?
What's happening on the markets this week.
Fed needs to ignore 'taper tantrums' and let longer rates rise
Financial Times: Central bank should take its cue from a baby sleep training technique.
Supply chain congestion troubles to get official airing
Container supply chain sectors best ones to solve commercial issues, says MoT.
Palantir: unlocked and almost loaded
Financial Times: A bullish signal should outweigh any post-pandemic sales slowdown.
Sharemarket edges closer to correction territory
Covid-related stocks like rertailers hardest hit
Gridlocked freight industry gathering for relief ideas
Any measures to ease freight choke can only be short term.
NZX-listed company CEO still under regulator's gaze
What's happening on the markets this week.
What Elon Musk's bitcoin moves proves about markets
What does it say when bizarre comments have the power to move markets?
Family sues US stock-trading app after young investor's suicide
Alex Kearns was 20 when he took his life after misunderstanding a potential trade loss.